Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · Real-Time Price · USD
41.24
-2.28 (-5.24%)
At close: Nov 2, 2026, 4:00 PM EST
41.56
+0.32 (0.78%)
After-hours: Nov 2, 2026, 7:30 PM EST
Ionis Pharmaceuticals Employees
Ionis Pharmaceuticals had 1,480 employees as of June 30, 2026. The number of employees increased by 78 or 5.56% since the number was reported on December 31, 2025. That makes Ionis Pharmaceuticals the 12,185th largest employer in the world and 1,925th in the United States.
Employees
1,480
Change
78
Growth
5.56%
Revenue / Employee
$590,603
Profits / Employee
-$381,874
Market Cap
6.85B
Employees Chart
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 1,480 | 78 | 5.56% |
| Dec 31, 2025 | 1,402 | 333 | 31.15% |
| Dec 31, 2024 | 1,069 | 142 | 15.32% |
| Dec 31, 2023 | 927 | 131 | 16.46% |
| Dec 31, 2022 | 796 | 136 | 20.61% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Axsome Therapeutics | 1,346 |
| Arrowhead Pharmaceuticals | 711 |
| Rhythm Pharmaceuticals | 414 |
| TG Therapeutics | 399 |
| Immunovant | 315 |
| Praxis Precision Medicines | 168 |
| Kodiak Sciences | 141 |
| ABIVAX Société Anonyme | 98 |
IONS News
- 5 hours ago - Ionis to hold third quarter 2026 financial results webcast - Business Wire
- 10 days ago - Roche says Sefaxersen trial shows meaningful reduction in proteinuria - TheFly
- 10 days ago - Ionis partner Roche announces new Phase 3 data showing sefaxersen significantly reduced proteinuria in people with IgA nephropathy (IgAN) - Business Wire
- 11 days ago - Ionis ranked #1 on Science's Top Employers list - Business Wire
- 11 days ago - Ionis treatment of Dravet syndrome granted FDA orphan status - TheFly
- 12 days ago - 5-star BMO analyst upgrades Ionis ahead of Q3 report - TheFly
- 12 days ago - Ionis Pharmaceuticals upgraded to Outperform from Market Perform at BMO Capital - TheFly
- 12 days ago - 3 Healthcare Stocks with Strong Buy Ratings and Double-Digit Upside - TipRanks